<SEC-DOCUMENT>0001004878-17-000246.txt : 20171201
<SEC-HEADER>0001004878-17-000246.hdr.sgml : 20171201
<ACCEPTANCE-DATETIME>20171201123013
ACCESSION NUMBER:		0001004878-17-000246
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20171128
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
FILED AS OF DATE:		20171201
DATE AS OF CHANGE:		20171201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEL SCI CORP
		CENTRAL INDEX KEY:			0000725363
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				840916344
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11889
		FILM NUMBER:		171233358

	BUSINESS ADDRESS:	
		STREET 1:		8229 BOONE BLVD .
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182
		BUSINESS PHONE:		7035069460

	MAIL ADDRESS:	
		STREET 1:		8229 BOONE BLVD.
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERLEUKIN 2 INC
		DATE OF NAME CHANGE:	19880317
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8k303ddeewar11-17.txt
<DESCRIPTION>FORM 8-K ITEM 3.03
<TEXT>


                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K


                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): November 28, 2017


                               CEL-SCI CORPORATION
                     --------------------------------------
             (Exact name of Registrant as specified in its charter)



      Colorado                         001-11889                 84-0916344
--------------------               ------------------        -----------------
(State or other jurisdiction      (Commission File No.)     (IRS Employer
of incorporation)                                            Identification No.)


                         8229 Boone Boulevard, Suite 802
                             Vienna, Virginia 22182
                     --------------------------------------
          (Address of principal executive offices, including Zip Code)



       Registrant's telephone number, including area code: (703) 506-9460


                                       N/A
                     --------------------------------------
          (Former name or former address if changed since last report)

                                       1
<PAGE>

Item 3.03.  Material Modification to Rights of Security Holders.

     On November 28, 2017 the Company extended the expiration date of its Series
DD and Series EE warrants to March 1, 2018. The Series DD and Series EE warrants
were  issued as part of a  financing  on  December  8, 2016.  As a result of the
reverse stock split  approved by the Company's  shareholders  and adopted by the
Company's directors,

     o    the  holders  of the  Series DD  warrants  are  entitled  to  purchase
          1,360,960 shares of the Company's common stock at an exercise price of
          $4.50 per share, and

     o    the  holders  of the  Series EE  warrants  are  entitled  to  purchase
          1,360,960 shares of the Company's common stock at an exercise price of
          $4.50 per share



















                                       2
<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


Date:  December 1, 2017            CEL-SCI CORPORATION



                                    By: /s/ Patricia Prichep
                                        --------------------------------
                                        Patricia Prichep
                                        Senior Vice President of Operations
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
